Company / Cash per Share
NewAmsterdam Pharma Co N.V. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$13.51
FY2025
5-year range
$9.39 / $21.28
FY2023-FY2025
Trend
-36.5%
vs FY2024
Sector context
#15 of 205
Health Care
What the data says
Among 205 Health Care companies, NewAmsterdam Pharma Co N.V. is in the top 7% for cash per share. Improved from $9.39 to $13.51 over the past 2 years.
Based on SEC 10-K filings.
13.51 in FY2025. Top quartile in the Health Care sector.
Improved from $9.39 to $13.51 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 205This company $13.51 Sector average $72.93
▼
-81.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 36.5% year-over-year.
- Ranks #15 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.51 | -36.5% |
| FY2024 | $21.28 | +126.7% |
| FY2023 | $9.39 | - |
| FY2022 | - | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026